Horiuchi K Y, Avrova S V, Chacko S
Institute of Cytology RAN, St. Petersburg, Russia.
Biochemistry. 1996 Oct 29;35(43):13849-57. doi: 10.1021/bi960996j.
Calponin, an actin/calmodulin-binding protein present in smooth muscle thin filaments, modulates the actin-myosin interaction and actomyosin ATPase activity of smooth muscle myosin II. Binding of myosin heads to actin under conditions that produce weak or strong binding induces conformational changes in actin. Polarized fluorimetric measurements of rhodamine-phalloidin complex and 1,5-IAEDANS specifically linked to actin in myosin-free muscle fibers (ghost fibers) and to Cys-707 in myosin head, respectively, revealed conformational changes, as determined from the changes in orientation and mobility of fluorescent probes, upon addition of calponin to ghost fibers. The effect of calponin on conformational changes produced upon binding of phosphorylated or dephosphorylated heavy meromyosin (HMM) was also determined. Subfragment-1 preparation modified with NEM (NEM-S1) or pPDM (pPDM-S1) were used as models of strong and weak binding, respectively. Calponin changed both the orientation of fluorophores on the actin and the flexibility of the actin filaments, as determined from the angle between an actin filament and the fiber axis. Changes in the flexibility of actin filaments and the orientation of fluorophores produced by phosphorylated smooth muscle HMM were similar to those seen with NEM-S1, which formed a strong-binding association with actin and caused the transition of actin monomers to the "on" state; calponin markedly inhibited this effect. In contrast, pPDM-S1 and dephosphorylated HMM induced weak binding and the transition of actin monomers to the "of" state, and these effects were enhanced by calponin. Furthermore, calponin decreased the velocity of actin filament movement over skeletal muscle myosin O gamma phosphorylated smooth muscle myosin heads in an in vitro motility assay. These results suggest that calponin induces modulation of smooth muscle contraction by inhibiting the force-producing (strong-binding) state of cross-bridges and involves changes in actin conformation.
钙调蛋白是一种存在于平滑肌细肌丝中的肌动蛋白/钙调蛋白结合蛋白,可调节肌动蛋白与肌球蛋白的相互作用以及平滑肌肌球蛋白II的肌动球蛋白ATP酶活性。在产生弱结合或强结合的条件下,肌球蛋白头部与肌动蛋白的结合会诱导肌动蛋白的构象变化。分别对与无肌球蛋白肌纤维(鬼纤维)中的肌动蛋白特异性连接的罗丹明-鬼笔环肽复合物和与肌球蛋白头部的Cys-707特异性连接的1,5-IAEDANS进行偏振荧光测量,结果显示,向鬼纤维中添加钙调蛋白后,根据荧光探针的方向和迁移率变化确定,出现了构象变化。还测定了钙调蛋白对磷酸化或去磷酸化重酶解肌球蛋白(HMM)结合时产生的构象变化的影响。分别用经NEM修饰的亚片段-1制剂(NEM-S1)或pPDM(pPDM-S1)作为强结合和弱结合的模型。钙调蛋白改变了肌动蛋白上荧光团的方向以及肌动蛋白丝的柔韧性,这是根据肌动蛋白丝与纤维轴之间的角度确定的。磷酸化平滑肌HMM产生的肌动蛋白丝柔韧性变化和荧光团方向变化与NEM-S1相似,NEM-S1与肌动蛋白形成强结合缔合并导致肌动蛋白单体转变为“开启”状态;钙调蛋白显著抑制了这种作用。相反,pPDM-S1和去磷酸化HMM诱导弱结合并使肌动蛋白单体转变为“关闭”状态,而钙调蛋白增强了这些作用。此外,在体外运动测定中,钙调蛋白降低了肌动蛋白丝在骨骼肌肌球蛋白Oγ磷酸化平滑肌肌球蛋白头部上的移动速度。这些结果表明,钙调蛋白通过抑制横桥的产生力(强结合)状态来诱导平滑肌收缩调节,并且涉及肌动蛋白构象的变化。